132 related articles for article (PubMed ID: 9950900)
1. EMAP II: a modulator of neovascularization in the developing lung.
Schwarz M; Lee M; Zhang F; Zhao J; Jin Y; Smith S; Bhuva J; Stern D; Warburton D; Starnes V
Am J Physiol; 1999 Feb; 276(2):L365-75. PubMed ID: 9950900
[TBL] [Abstract][Full Text] [Related]
2. Potential role for antiangiogenic proteins in the evolution of bronchopulmonary dysplasia.
Quintos-Alagheband ML; White CW; Schwarz MA
Antioxid Redox Signal; 2004 Feb; 6(1):137-45. PubMed ID: 14713345
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
[TBL] [Abstract][Full Text] [Related]
4. Temporo-spatial distribution of endothelial-monocyte activating polypeptide II, an anti-angiogenic protein, in the mouse embryo.
Zhang F; Schwarz MA
Dev Dyn; 2000 Jul; 218(3):490-8. PubMed ID: 10878614
[TBL] [Abstract][Full Text] [Related]
5. Expression of EMAP II in the developing and adult mouse.
Knies UE; Kröger S; Clauss M
Apoptosis; 2000 Apr; 5(2):141-51. PubMed ID: 11232242
[TBL] [Abstract][Full Text] [Related]
6. Potential role for antiangiogenic proteins in the myocardial infarction repair process.
Thompson JL; Ryan JA; Barr ML; Franc B; Starnes VA; Schwarz MA
J Surg Res; 2004 Jan; 116(1):156-64. PubMed ID: 14732363
[TBL] [Abstract][Full Text] [Related]
7. Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis.
Schwarz MA; Zhang F; Gebb S; Starnes V; Warburton D
Mech Dev; 2000 Jul; 95(1-2):123-32. PubMed ID: 10906456
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
[TBL] [Abstract][Full Text] [Related]
9. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal interactions are linked to neovascularization.
Schwarz MA; Wan Z; Liu J; Lee MK
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):784-92. PubMed ID: 14672913
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
[TBL] [Abstract][Full Text] [Related]
12. Expression and function of endothelial monocyte-activating polypeptide-II in acute lung inflammation.
Journeay WS; Janardhan KS; Singh B
Inflamm Res; 2007 May; 56(5):175-81. PubMed ID: 17393072
[TBL] [Abstract][Full Text] [Related]
13. Regulation of EMAP II by hypoxia.
Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
[TBL] [Abstract][Full Text] [Related]
14. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis.
Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12322-7. PubMed ID: 9770485
[TBL] [Abstract][Full Text] [Related]
15. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of endothelial monocyte-activating polypeptide II in the human endometrium across the menstrual cycle: regulation of expression by prostaglandin E(2).
Battersby S; Boddy SC; Critchley HO; Jabbour HN
J Clin Endocrinol Metab; 2002 Aug; 87(8):3928-35. PubMed ID: 12161535
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
[TBL] [Abstract][Full Text] [Related]
18. In vivo therapy of local tumor progression by targeting vascular endothelium with EMAP-II.
Schwarz RE; Schwarz MA
J Surg Res; 2004 Jul; 120(1):64-72. PubMed ID: 15172191
[TBL] [Abstract][Full Text] [Related]
19. Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).
Lal CV; Schwarz MA
Birth Defects Res A Clin Mol Teratol; 2014 Mar; 100(3):180-8. PubMed ID: 24619875
[TBL] [Abstract][Full Text] [Related]
20. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
